By adding change in body weight after 5 weeks of treatment as a covariate to the statistical model in a post hoc analysis, the treatment-related differences in 24-h EE as described above were reduced (2%, P =0.21 and 3%, P =0.02 for liraglutide 1.8 mg and 3.0 mg versus placebo, respectively
Lifestyle factors including diet composition, meal timing, sleep quality, and stress levels interact with semaglutide's pharmacological effects
Significant advances have been in the research and development of semaglutide for weight loss treatment
Vijayakumar A, Aryal P, Wen J, Syed I, Vazirani RP, Moraes-Vieira PM, et al
Rather than promising unproven benefits, focus on patient goals and safe, evidencebased care
Curious to give it a go